Mission Bio recently announced a $30+ million Series B funding round to scale up their single-cell DNA analysis platforms and expand into global markets. Mission Bio uses microfluidics, droplet PCR, and custom barcoding...
Automation and hardware
SynBioBeta Deep Dive webinar with Tierra Biosciences and Labcyte
If you want to disrupt the natural products market, try combining acoustic liquid handling technology with advances in cell-free approaches. Join Zachary Sun, CEO of Tierra Biosciences (formerly Synvitrobio), to hear...
